Literature DB >> 33753491

Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.

Cyril Le Nouën1, Thomas McCarty2, Lijuan Yang2, Michael Brown3, Eckard Wimmer4, Peter L Collins2, Ursula J Buchholz2.   

Abstract

Recoding viral genomes by introducing numerous synonymous but suboptimal codon pairs-called codon-pair deoptimization (CPD)-provides new types of live-attenuated vaccine candidates. The large number of nucleotide changes resulting from CPD should provide genetic stability to the attenuating phenotype, but this has not been rigorously tested. Human respiratory syncytial virus in which the G and F surface glycoprotein ORFs were CPD (called Min B) was temperature-sensitive and highly restricted in vitro. When subjected to selective pressure by serial passage at increasing temperatures, Min B substantially regained expression of F and replication fitness. Whole-genome deep sequencing showed many point mutations scattered across the genome, including one combination of six linked point mutations. However, their reintroduction into Min B provided minimal rescue. Further analysis revealed viral genomes bearing very large internal deletions (LD genomes) that accumulated after only a few passages. The deletions relocated the CPD F gene to the first or second promoter-proximal gene position. LD genomes amplified de novo in Min B-infected cells were encapsidated, expressed high levels of F, and complemented Min B replication in trans This study provides insight on a variation of the adaptability of a debilitated negative-strand RNA virus, namely the generation of defective minihelper viruses to overcome its restriction. This is in contrast to the common "defective interfering particles" that interfere with the replication of the virus from which they originated. To our knowledge, defective genomes that promote rather than inhibit replication have not been reported before in RNA viruses.
Copyright © 2021 the Author(s). Published by PNAS.

Entities:  

Keywords:  codon-pair deoptimization; defective genomes; genetic stability; negative-strand RNA virus; respiratory syncytial virus

Year:  2021        PMID: 33753491      PMCID: PMC8020775          DOI: 10.1073/pnas.2020969118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro.

Authors:  Josephine M McAuliffe; Sonja R Surman; Jason T Newman; Jeffrey M Riggs; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Virus attenuation by genome-scale changes in codon pair bias.

Authors:  J Robert Coleman; Dimitris Papamichail; Steven Skiena; Bruce Futcher; Eckard Wimmer; Steffen Mueller
Journal:  Science       Date:  2008-06-27       Impact factor: 47.728

3.  Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.

Authors:  Cyril Le Nouën; Thomas McCarty; Michael Brown; Melissa Laird Smith; Roberto Lleras; Michael A Dolan; Masfique Mehedi; Lijuan Yang; Cindy Luongo; Bo Liang; Shirin Munir; Joshua M DiNapoli; Steffen Mueller; Eckard Wimmer; Peter L Collins; Ursula J Buchholz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

4.  Genetic recombination during coinfection of two mutants of human respiratory syncytial virus.

Authors:  Kirsten M Spann; Peter L Collins; Michael N Teng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Paramyxovirus ultrastructure and genome packaging: cryo-electron tomography of sendai virus.

Authors:  Colin Loney; Geneviève Mottet-Osman; Laurent Roux; David Bhella
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 6.  Why do RNA viruses recombine?

Authors:  Etienne Simon-Loriere; Edward C Holmes
Journal:  Nat Rev Microbiol       Date:  2011-07-04       Impact factor: 60.633

7.  Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells.

Authors:  Antoine Nougairede; Lauriane De Fabritus; Fabien Aubry; Ernest A Gould; Edward C Holmes; Xavier de Lamballerie
Journal:  PLoS Pathog       Date:  2013-02-21       Impact factor: 6.823

8.  Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Authors:  Karla Tapia; Won-Keun Kim; Yan Sun; Xiomara Mercado-López; Emily Dunay; Megan Wise; Michael Adu; Carolina B López
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

9.  Extensive recoding of dengue virus type 2 specifically reduces replication in primate cells without gain-of-function in Aedes aegypti mosquitoes.

Authors:  Charles B Stauft; Sam H Shen; Yutong Song; Oleksandr Gorbatsevych; Emmanuel Asare; Bruce Futcher; Steffen Mueller; Anne Payne; Matthew Brecher; Laura Kramer; Eckard Wimmer
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

10.  Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients.

Authors:  Jasmina Vasilijevic; Noelia Zamarreño; Juan Carlos Oliveros; Ariel Rodriguez-Frandsen; Guillermo Gómez; Guadalupe Rodriguez; Mercedes Pérez-Ruiz; Sonia Rey; Isabel Barba; Francisco Pozo; Inmaculada Casas; Amelia Nieto; Ana Falcón
Journal:  PLoS Pathog       Date:  2017-10-12       Impact factor: 6.823

View more
  1 in total

1.  Reversion mutations in phosphoprotein P of a codon-pair-deoptimized human respiratory syncytial virus confer increased transcription, immunogenicity, and genetic stability without loss of attenuation.

Authors:  Jessica W Chen; Lijuan Yang; Celia Santos; Sergio A Hassan; Peter L Collins; Ursula J Buchholz; Cyril Le Nouën
Journal:  PLoS Pathog       Date:  2021-12-29       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.